A detailed history of Acadian Asset Management LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 627 shares of STTK stock, worth $695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
627
Previous 44,193 98.58%
Holding current value
$695
Previous $170,000 98.82%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.0 - $4.85 $130,698 - $211,295
-43,566 Reduced 98.58%
627 $2,000
Q2 2024

Aug 06, 2024

BUY
$3.56 - $11.18 $157,327 - $494,077
44,193 New
44,193 $170,000
Q2 2022

Aug 09, 2022

SELL
$2.7 - $4.59 $24,054 - $40,892
-8,909 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$4.22 - $8.89 $37,595 - $79,201
8,909 New
8,909 $37,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $47M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.